Archive

February 13, 2018

Transformative Investments

University Communications | Research & Discovery

Transformative investments text overlayed on an image of the statue of Icarus
This archived version of the article may not include all of the features that appeared in the original publication. The content has been adapted to meet current website accessibility requirements.

The Board of Visitors established the Strategic Investment Fund in 2016 to serve as a funding source for initiatives that have the potential to transform a critical area of knowledge or operation within the university.

The timing couldn’t be more appropriate.

UVA stands on the cusp of its third century in service to the state, nation and world, with ambitions to dramatically build on its mission to prepare citizen leaders and offer higher education leadership for tomorrow in a continuous pursuit of excellence. Transformative investments provide crucial support to power these ambitions and ideas, and they are critically needed in a time of tremendous pressure on the business model for public higher education.

The Strategic Investment Fund is a powerful tool to help accomplish that work. Without relying on tuition or tax dollars, the fund is projected to support up to $100 million annually in perpetuity for projects or areas with the potential to significantly advance the quality of education, research or health care services at UVA.

Since the fund launched, the Board has approved more than $307 million in support of 33 projects that fall under one of four broad investment areas: research, research infrastructure, academic experience, and access and affordability.

Initial investments have included new endowments enabling student scholarships and professorships, research and strategies that aim to end Type 1 diabetes, an initiative created to strengthen global democracy, and a cross-disciplinary center that could one day regenerate human tissue.

Proposals undergo a rigorous review process, and projects selected for investment must demonstrate measurable return on their stated goals and promise.

Here are some of the bold initiatives earning support from the Strategic Investment Fund.

Academic Experience

Soaring Out of Africa

Kevin Bahati experienced first-hand the consequences of not having reliable access to clean water. “I’ve been affected by water-related diseases for most of my life,” said Bahati, who has lived in Congo, Zambia and Uganda.

At UVA, Bahati already is working toward his goal of improving conditions back home by working in chemical engineering professor Geoffrey Geise’s water purification lab. Bahati’s involvement is made possible through the USOAR program, which helps undergraduate students get research experience early in their college careers.

“It’s a good experience because it challenges me, and I’m loving it,” said Bahati, who plans to take what he’s learning in USOAR and apply it to the water-quality issues plaguing his native Africa. According to USOAR Director Brian Cullaty, that’s the idea: “We want USOAR to be the introductory program into research where students get experience and can go on to do something great in the future.”

Kevin Bahati - “I really hope to have mastered what I’ve learned and to be somewhat of an expert in the research field. Then, if I can go back home after college, it would make it possible for me to contribute and make things better.”

Affordability and Access

A Foundation of Our Future

The Bicentennial Scholars Fund is the latest step to provide students and their families access to one of the finest undergraduate educations in the country.

“Investing in scholarships opens the doors of the University of Virginia even wider for all admitted students, regardless of their ability to pay,” said Board of Visitors member John A. Griffin, who chairs the Advancement Committee. “The Bicentennial Scholars Fund matching component provides an important incentive to continue our focus on this critical fundraising area, which is key to the long-term success and sustainability of the University.”

The Board and administration have been building a framework for sustainable, long-term financing for operations and strategic priorities, while pursuing ways to ensure and sustain affordability. The Bicentennial Scholars Fund helps put the University on a reliable financial path for its third century while also strengthening its ability to offer an excellent education that does not overburden Virginia families.

John A. Griffin - “The Bicentennial Scholars Fund is an important demonstration of UVA’s full commitment to ensuring the best and brightest can attend regardless of their ability to pay.”

Research

Once and for All

Dr. Richard P. Shannon, executive vice president for health affairs at the UVA Health System, said the diabetes-related investment will allow medical researchers to focus as never before on finding a cure for the disease. “The investment will allow us to develop further our artificial pancreas studies, create a statewide genomics screening program to identify children at risk of developing Type 1 diabetes and advance our existing work on human beta cell regeneration,” Shannon said.

In individuals with Type 1 diabetes, beta cells — which are found in the pancreas and are responsible for producing insulin — get destroyed. If regeneration of beta cells were possible, though, the body’s own ability to make insulin could be restored. Project success would make the University a global leader in Type 1 diabetes and would position UVA to undertake future research in related areas involving genomics, data science and immune therapy.

Dr. Richard P. Shannon - “Our goal is to provide better care for patients in the short term while transforming patients’ lives in the long term by finding a cure.”

Research Infrastructure

Putting Soldiers Back Together

George J. Christ, a UVA Professor of biomedical engineering and orthopaedic surgery and expert in regenerative medicine, wants to help combat-injured soldiers with soft-tissue injuries from explosive devices. “A doctor can fix you to some extent, but nobody’s talking about how you can actually get your muscle back,” he says.

The Advanced Regenerative Manufacturing Institute’s goal is to accelerate regenerative tissue research and create state-of-the-art innovations in biomaterial and cell processing. A public/private effort, the Institute brings together UVA and nearly 100 partners from industry, government, academia and the non-profit sector.

The schools of Engineering and Medicine bring expertise in cell and tissue engineering, regenerative medicine, orthopaedics, computational modeling, advanced materials research and chemical engineering. Christ pursued the opportunity for UVA to participate in the consortium, working with biomedical engineering professor Shayn Peirce-Cottler to identify a team of physicians and researchers, including Dr. Bobby Chhabra, chair of orthopaedic surgery for UVA Health System.

George J. Christ - “The consortium was looking for partners that are collaborative, with the expertise and facilities to do something truly translational and clinically relevant. They saw the value in the innovative things we’re doing here at UVA.”